Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-03-23

Clinical Trial Update: Minocycline Augmentation in Schizophrenia [NA]

View source ↗

Summary

A clinical trial is evaluating minocycline augmentation for schizophrenia. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Schizophrenia | NA | Status: UNKNOWN